WHO approves emergency use listing for Serum Institute of India manufactured Covovax

World Health Organisation (WHO) has issued an emergency use listing for Serum Institute of India’s manufactured Covovax. The move will help expand the basket of WHO-validated vaccines against the SARS-CoV-2 virus. In a statement, WHO said, the decision will give a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries.

The Serum Institute of India (SII) is producing Covovax under licence from Novavax and is part of the COVAX facility portfolio. Taking to Twitter, SII CEO Adar Poonawalla said, this is yet another milestone in our fight against Covid-19. He said, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy.

Click to comment

Leave a Reply

Your email address will not be published.

seven + 5 =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

West Bengal

Eastern Regional Office
Indsamachar Digital Media
Siddha Gibson 1,
Gibson Lane, 1st floor, R. No. 114,
Kolkata – 700069.
West Bengal.

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us